Business
/C O R R E C T I O N -- American Healthcare REIT, Inc./
American Healthcare REIT, Inc. (the "Company," "we," "our," "management," or "us") (NYSE: AHR) announced today its first quarter 2025 results and is increasing full year 2025 guidance.
About this update from American Healthcare Reit, Inc.
[{"type":"text","content":"In the news release, American Healthcare REIT ("AHR") Announces First Quarter 2025 Results; Increases Full Year 2025 Guidance, issued 08-May-2025 by American Healthcare REIT, Inc. over PR Newswire, we are advised by the company that in the table "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS For the Three Months Ended March 31, 2025 and 2024" the row of "Loss from unconsolidated entities" had incorrect amounts. The complete, corrected release follows:","length":510,"tagName":"p"},{"type":"heading","content":"American Healthcare REIT ("AHR") Announces First Quarter 2025 Results; Increases Full Year 2025 Guidance","length":114,"tagName":"h3","attribs":{}},{"type":"text","content":"IRVINE, Calif., May 8, 2025 /PRNewswire/ -- American Healthcare REIT, Inc. (the "Company," "we," "our," "management," or "us") (NYSE: AHR) announced today its first quarter 2025 results and is increasing full year 2025 guidance.","length":283,"tagName":"p"},{"type":"image","alt":"American Healthcare REIT logo (PRNewsfoto/American Healthcare Investors)","displaySize":"","headline":null,"caption":"American Healthcare REIT logo (PRNewsfoto/American Healthcare Investors)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":153,"url":"https://media.zenfs.com/en/prnewswire.com/f908ec7ff2819cfdcc5d5aa6a0449fba"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XWkJVZdmh5m90NLZW.UVSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI3MDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/f908ec7ff2819cfdcc5d5aa6a0449fba","width":400,"height":153}},"href":"https://mma.prnewswire.com/media/1641068/American_Healthcare_REIT_logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Key Highlights:","length":15,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Reported GAAP net loss attributable to controlling interest of $(6.8) million and GAAP net loss attributable to common stockholders of $(0.04) per diluted share for the three months ended March 31, 2025.","length":203,"tagName":"p"}]},{"val":[{"type":"text","content":"Reported Normalized Funds from Operations attributable to common stockholders ("NFFO") of $0.38 per diluted share for the three months ended March 31, 2025.",...